2 Page Information Sheet
Behavioral2 page information sheet about medication abortion
NCT Number: NCT04307641
The purpose of this study is to understand the effect of providing pharmacists in UP, India with additional information about medication abortion.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
This study evaluates whether providing pharmacists with additional information about medication abortion can improve abortion person-centered care for women accessing MA at these sites.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 page information sheet about medication abortion
Time frame: baseline compared to 6-months after intervention
self-reported survey (dose, time, side effects, complications)
Time frame: 3-months post intervention
Information provided to mystery clients regarding MA (dose, time, side effects, complications)
Time frame: 6-months after intervention
self-reported survey on interest and satisfaction
University of California, San Francisco
Other
Strengthening Patient-Centered Accessibility, Respect, and Quality of Care for Abortion Clients in UP, India
Acronym: SPARQ_ACI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07711782
Adnexal Diseases, Cysts
Lahore, Pakistan
View Trial DetailsNCT06215183
Anxiety Disorders, Behavior
Istanbul, Pendik, Turkey (Türkiye)
View Trial DetailsNCT07351084
Contraceptive Device Failure, Female Contraception
Kansas City, Kansas, United States
View Trial DetailsNCT07275671
Adnexal Diseases, Endocrine System Diseases
Shanghai, China
View Trial Details